Wessanen announced after having served as the company's Chief Financial Officer and Executive Board member for eight years, Mr. Ronald Merckx will leave the company to become CFO of Centrient Pharmaceuticals. Mr. Merckx's current term will expire at the company AGM of 11 April 2019.